XML 188 R174.htm IDEA: XBRL DOCUMENT v3.22.2
Schedule I - Condensed Financial Information of Parent (Exelon Corporate) - Condensed Balance Sheet (Details) - USD ($)
shares in Millions, $ / shares in Millions, $ in Millions
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Current assets        
Cash and cash equivalents $ 672 $ 432 $ 587 $ 1,349
Accounts receivable        
Other accounts receivable, net 996 1,046    
Regulatory assets, current 1,296 1,228    
Other 387 223    
Total current assets 13,957 12,562    
Property, plant and equipment, net 64,558 60,332    
Deferred debits and other assets        
Regulatory assets, noncurrent 8,224 8,759    
Other 885 1,143    
Total deferred debits and other assets 54,498 56,423    
Total assets [1] 133,013 129,317    
Current liabilities        
Short-term borrowings 1,248 1,191    
Long-term debt due within one year 2,153 1,622    
Accounts payable 2,379 2,309    
Accrued expenses 1,137 1,230    
Payables to affiliates, current 5 5    
Regulatory liabilities, current 376 581    
Other 766 784    
Total current liabilities 16,111 12,771    
Long-term debt 30,749 29,527    
Deferred credits and other liabilities        
Regulatory liabilities, noncurrent 9,628 9,485    
Pension obligations 2,051 2,946    
Non-pension postretirement benefits obligations 811 1,002    
Other 1,573 1,642    
Total deferred credits and other liabilities 50,968 51,761    
Total liabilities [1] 98,218 94,449    
Commitments and contingencies    
Shareholders’ equity        
Common Stock, No Par Value $ 0 $ 0    
Common Stock, Shares Authorized 2,000 2,000    
Common Stock, Shares, Outstanding 979 976    
Common stock $ 20,324 $ 19,373    
Treasury Stock, Shares 2 2    
Treasury stock, at cost $ (123) $ (123)    
Retained earnings 16,942 16,735    
Accumulated other comprehensive loss, net (2,750) (3,400)    
Total shareholders’ equity 34,393 32,585    
Total liabilities and equity 133,013 129,317    
Corporate, Non-Segment [Member]        
Current assets        
Cash and cash equivalents 295 63    
Accounts receivable        
Other accounts receivable, net 318 354    
Accounts receivable from affiliates, current 35 11    
Note receivable from affiliates, current 217 598    
Regulatory assets, current 266 315    
Other 41 (23)    
Total current assets 1,172 1,318    
Property, plant and equipment, net 45 46    
Deferred debits and other assets        
Regulatory assets, noncurrent 3,164 3,816    
Investments in affiliates 29,563 27,140    
Deferred income taxes 1,351 1,436    
Notes receivable from affiliates, noncurrent 319 324    
Other 42 312    
Total deferred debits and other assets 46,772 45,977    
Total assets 47,989 47,341    
Current liabilities        
Short-term borrowings 650 500    
Long-term debt due within one year 1,150 300    
Accounts payable 0 1    
Accrued expenses 47 66    
Payables to affiliates, current 360 457    
Regulatory liabilities, current 3 4    
Pension obligations 49 61    
Other 40 (1)    
Total current liabilities 2,299 1,388    
Long-term debt 6,265 7,418    
Deferred credits and other liabilities        
Regulatory liabilities, noncurrent 63 32    
Pension obligations 4,416 5,236    
Non-pension postretirement benefits obligations 87 236    
Deferred income taxes 362 360    
Other 104 86    
Total deferred credits and other liabilities 5,032 5,950    
Total liabilities 13,596 14,756    
Commitments and contingencies    
Shareholders’ equity        
Common Stock, No Par Value $ 0 $ 0    
Common Stock, Shares Authorized 2,000 2,000    
Common Stock, Shares, Outstanding 979 976    
Common stock $ 20,324 $ 19,373    
Treasury Stock, Shares 2 2    
Treasury stock, at cost $ (123) $ (123)    
Retained earnings 16,942 16,735    
Accumulated other comprehensive loss, net (2,750) (3,400)    
Total shareholders’ equity 34,393 32,585    
Total liabilities and equity $ 47,989 $ 47,341    
[1] Exelon’s consolidated assets include $18 million as of December 31, 2020, of certain VIEs that can only be used to settle the liabilities of the VIE. Exelon’s consolidated liabilities include $26 million as of December 31, 2020, of certain VIEs for which the VIE creditors do not have recourse to Exelon. See Note 21–Variable Interest Entities for additional information.